A new market study, titled “Cell Banking Outsourcing – Global Market Outlook (2017-2023)”, has been featured on WiseGuyReports.

According to research report, the Global Cell Banking Outsourcing Market is accounted for $3.2 billion in 2016 and expected to grow at a CAGR of 20.0% to reach $11.87 billion by 2023. Factors such as tissues required for R&D, cells for the regenerative medicine production, demand for stem cell therapies, increasing number of cord blood banks, development of sophisticated preservation technologies, demand for monoclonal antibodies, increasing prevalence of cancer, demand for ready-to-use bioassay banks are augmenting the market growth. Regenerative medicine, tissue engineering and gene therapy offer the opportunity for curing, number of elderly patients has also significantly increased, and recently adipose tissue banking has become available and offers opportunity to store stem cells for future use. These are the few trends observed by the market. However, ethical concerns related to stem cell research, high cost of therapies, risk of contamination of cell lines by manual errors or environmental conditions are impeding the market growth.

Based on Cell Type, for Stem Cell Banking there is no scientific evidence to substantiate clinical benefits with the use of stem cells derived from cord tissue, placenta, tooth extract etc. Yet, procurement and banking of these biological is increasingly becoming a commercial activity. For example, use of Umbilical Cord Blood (UCB) derived HSCs for treatment of various haematological and immunological disorders is currently well established. Cord blood stored in private banks is used for either autologous or allogeneic transplants. However, few challenges like regulatory issues, licensure, have increased the cost to bank and some obstetrical practices have been observed.

Based on Bank Master cell bank represents a cell reserve “frozen-in-time”. It prevents contamination and deterioration. The Master cell bank is used for ensuring a stock of cells to avoid genetic variation within the cell culture. Biosafety testing and characterization methods include sterility and mycoplasma testing, C01 Barcode assay, in vitro and in vivo assays for adventitious viral contaminants, reverse transcription assays, transmission electron microscopy, PCR and qPCR assays, bovine and porcine virus assays, and retroviral infectivity assays.

North America accounted for the largest share due to high number of research and development projects and growing need for vaccines. Asia Pacific is anticipated to witness significant growth owing to investments in biotechnology sector, R&D activities for cancer treatment and fertility preservation.

– Strategic recommendations in key business segments based on the market estimations

– Competitive landscaping mapping the key common trends

– Company profiling with detailed strategies, financials, and recent developments

– Supply chain trends mapping the latest technological advancements

Table of Content

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global Cell Banking Outsourcing Market, By Bank

6 Global Cell Banking Outsourcing Market, By Phase

7 Global Cell Banking Outsourcing Market, By Cell Type

8 Global Cell Banking Outsourcing Market, By Geography

9 Key Developments

10 Company Profiling

About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Event Details

PULSUS group cordially welcomes researchers, academicians, students and business professionals in the field of Cancer Science and Therapy from around

more

Event Details

PULSUS group cordially welcomes researchers, academicians, students and business professionals in the field of Cancer Science and Therapy from around the world to participate in the upcoming “2nd World Congress on Advanced Cancer Science & Therapy” to be held at Dubai, UAE during January 28-29, 2019. The meeting for this year will revolve around the theme “An Assembly of Curious Facts and Cure for Cancer” thus relaying the most cutting-edge findings in this field.

The two-day meeting is going to be an event to look forward for its enlightening symposiums & workshops from established experts in cancer therapy, potential keynote talks from eminent speakers, informative oral sessions and innovative poster presentations.

Cancer Therapy 2019 is an extraordinary event that invites participants from different leading universities, clinical research institutions and various diagnostic companies to share their research experiences in all aspects of this rapidly expanding field and provides an opportunity to meet and communicate with leading doctors, surgeons, scientists, academic professionals from around the world and listen to top speakers on new developments that impact and advance future of cancer science. It serves as a global platform to know about the current developments and new approaches in the field of cancer science and therapy. It will also prove to be a brilliant open door for businesses keen on expanding their global market reach. This event is an effort to understand the underlying new techniques which are amended to increase effectiveness, accuracy, sustainability, and quality of life.